Status Migrainosus Diagnosis and Management

Diagnostic Considerations

The probability of finding a clinically significant intracranial abnormality in a migraine patient with a normal neurological examination is only 0.2%, which is no higher than the rate of incidental findings in completely asymptomatic individuals, according to the American Academy of Neurology 1, 2, 3
Neuroimaging is not usually warranted for patients with migraine and normal neurological examination, as stated by the American College of Radiology 1, 2

Abnormal findings on neurological examination, headache that awakens from sleep, progressive worsening over weeks, headache worsened by Valsalva maneuver, new-onset headache in a patient over 50 years, or rapid increase in headache frequency are indications for further imaging, according to the American College of Emergency Physicians 1, 2
MRI is more sensitive for detecting ischemia, venous thrombosis, and smaller lesions, although the yield remains extremely low (0.2%) in patients with normal neurological examination and typical migraine features, as noted by the American College of Radiology 1, 4

The 4-day duration indicates the patient needs acute rescue therapy for status migrainosus, not further diagnostic workup, according to the American Academy of Family Physicians 5
First-line acute treatment includes NSAIDs or the acetaminophen-aspirin-caffeine combination, with triptans or dihydroergotamine (DHE) used for moderate-to-severe attacks not responding to NSAIDs, as recommended by the American Headache Society 5, 6
Limit acute treatment to no more than twice weekly to prevent medication-overuse headache, as advised by the American Academy of Neurology 5, 6